4 Aug 2015 14:43
4 August 2015
Immunodiagnostic Systems Holdings PLC
AGM Results
Immunodiagnostic Systems Holdings PLC ("IDS" or "the Company" or "the Group"), a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, today announces the results of its Annual General Meeting (the "Meeting") that was held at 2 p.m. today.
Trading update
Dr Burkhard Wittek, Non-executive Chairman, provided a business update at the Meeting and a copy of the trading statement has been made available on the Company's website.
Voting Results
All resolutions put to the meeting were decided on a show of hands and all were duly passed.
For information, details of the proxy voting are shown below:
Resolution | Votes for | Votes For (as % of votes cast) | Votes Against (as % of votes cast) | Votes Withheld |
1. To receive the accounts for the financial year ended 31 March 2015 together with the reports of the Directors and of the Auditor thereon. | 14,659,583 | 100.00 | 0.00 | 436,987 |
2. To declare a final dividend for the financial year ended 31 March 2015. | 14,659,583 | 100.00 | 0.00 | 436,987 |
3. To elect as a Director of the Company Mr Till Campe. | 14,643,963 | 99.89 | 0.11 | 436,987 |
4. To elect as a Director of the Company Mr Patricio Lacalle. | 14,656,083 | 99.98 | 0.02 | 436,987 |
5. To elect as a Director of the Company Dr Burkhard Wittek. | 14,524,136 | 99.08 | 0.92 | 436,987 |
6. To elect as a Director of the Company Mr Peter Williamson. | 14,659,583 | 100.00 | 0.00 | 436,987 |
7. To re-appoint Ernst & Young LLP as Auditor of the Company. | 14,659,583 | 100.00 | 0.00 | 436,987 |
8. To authorise the Directors of the Company to determine the remuneration of the Auditor of the Company. | 14,659,583 | 100.00 | 0.00 | 436,987 |
9. To approve the Directors' Remuneration Report for the financial year ended 31 March 2015. | 14,475,556 | 98.74 | 1.26 | 436,987 |
10. To authorise the Directors to allot relevant securities. | 14,659,283 | 100.00 | 0.00 | 436,987 |
11. To authorise the disapplication of pre-emption rights in accordance with section 570 of the Companies Act 2006. | 14,659,583 | 97.11 | 2.89 | 0 |
12. To authorise the Directors to make market purchases. | 14,659,583 | 100.00 | 0.00 | 436,987 |
13. To approve the Immunodiagnostic Systems Holdings PLC Executive Share Option Scheme | 10,708,609 | 73.05 | 26.95 | 437,037 |
The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the IDS website (www.idsplc.com).
For further information:
Immunodiagnostic Systems Holdings plc | Tel : +44 (0)191 519 0660 |
Patricio Lacalle, Chief Executive Officer | |
Peel Hunt LLP | Tel : +44 (0)207 418 8900 |
James Steel | |
Clare Terlouw |